Borrelia Burgdorferi Bacterin

475 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

475

Total Reports

Deaths Reported

270.0%

Death Rate

Active Ingredients

Borrelia Burgdorferi Bacterin

Administration Routes

SubcutaneousParenteralUnknownOther

Species Affected

Dog 475

Most Affected Breeds

Retriever - Labrador 76

Retriever - Golden 56

Shepherd Dog - German 33

Crossbred Canine/dog 20

Collie - Border 19

Shepherd Dog - Australian 18

Beagle 15

Mountain Dog - Bernese 12

Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 9

Pit Bull 9

Most Reported Reactions

Lack of efficacy (bacteria) - Borrelia 270

Lack of efficacy (ectoparasite) - tick NOS 123

Other abnormal test result NOS 106

Lethargy (see also Central nervous system depression in 'Neurological') 28

Vomiting 25

Limping 24

Diarrhoea 22

Lack of efficacy (tick) 20

Lack of efficacy (bacteria) - NOS 20

Urine abnormalities NOS 16

Proteinuria 16

Lack of efficacy (bacteria) - Anaplasma 16

Outcome Breakdown

Outcome Unknown

357 (75.2%)

Ongoing

61 (12.8%)

Recovered/Normal

44 (9.3%)

Died

7 (1.5%)

Euthanized

6 (1.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.